Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
10.41
+0.80 (8.32%)
At close: Aug 7, 2026, 4:00 PM EDT
10.42
+0.01 (0.10%)
After-hours: Aug 7, 2026, 6:29 PM EDT
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $310.09 million as of August 7, 2026.
Market Cap
310.09M
Enterprise Value
304.88M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.41
ChartMarket Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has increased from $196.16M to $310.09M, an increase of 58.08%. That is a compound annual growth rate of 73.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 310.09M | 167.29% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 326.37M |
| Agenus | 311.48M |
| Anavex Life Sciences | 309.52M |
| Vanda Pharmaceuticals | 302.31M |
| Opus Genetics | 302.19M |
| Neumora Therapeutics | 302.01M |
| Zentalis Pharmaceuticals | 300.41M |
| SAB Biotherapeutics | 298.21M |